Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To provide ganciclovir on a compassionate use basis to immunocompromised patients with
serious cytomegalovirus (CMV) infections and to study safety and efficacy in this patient
population.